Literature DB >> 28303445

Interactive Effect of Parent and Adolescent Psychiatric Symptoms on Substance Use among Adolescents in Community Treatment.

Lourah M Kelly1, Sara J Becker2,3, Jennifer C Wolff3, Hannah Graves3, Anthony Spirito3.   

Abstract

Both adolescent and parent psychiatric symptoms are well-established risk factors for adolescent substance use (SU), but the ways that these symptoms interact are not well understood. This study examined the interactive effects of parent and adolescent psychiatric symptoms on adolescent frequency of alcohol and marijuana use, over and above the effects of parental SU. Seventy adolescents presenting to a community mental health center (CMHC) participated. Parent and adolescent psychiatric symptoms were measured with the brief symptom inventory (BSI) and child behavior checklist (CBCL), respectively. Hierarchical regressions revealed different patterns for adolescent alcohol and marijuana use. For alcohol, the BSI parent phobic anxiety subscale predicted increased adolescent use while the parent interpersonal sensitivity subscale predicted decreased use: the effects of these parental symptoms were strongest among adolescents with higher levels of externalizing problems on the CBCL. For marijuana, the BSI parent psychoticism subscale predicted increased adolescent use, whereas paranoid ideation predicted decreased use. Results suggest that adolescent SU treatment and assessment should attend to both adolescent and parent psychiatric symptoms.

Entities:  

Keywords:  Adolescent; Community behavioral health clinic; Psychiatric symptoms; Substance use

Mesh:

Year:  2017        PMID: 28303445      PMCID: PMC6431791          DOI: 10.1007/s10597-017-0110-2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  31 in total

Review 1.  Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations.

Authors:  Grayson N Holmbeck
Journal:  J Pediatr Psychol       Date:  2002 Jan-Feb

Review 2.  Adolescent substance use and family-based risk and protective factors: a literature review.

Authors:  H F Vakalahi
Journal:  J Drug Educ       Date:  2001

Review 3.  Evidence-based psychosocial treatments for adolescent substance abuse.

Authors:  Holly Barrett Waldron; Charles W Turner
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

4.  Genetic predisposition to schizophrenia associated with increased use of cannabis.

Authors:  R A Power; K J H Verweij; M Zuhair; G W Montgomery; A K Henders; A C Heath; P A F Madden; S E Medland; N R Wray; N G Martin
Journal:  Mol Psychiatry       Date:  2014-06-24       Impact factor: 15.992

5.  Comorbidity of substance misuse and mental illness in community mental health and substance misuse services.

Authors:  T Weaver; P Madden; V Charles; G Stimson; A Renton; P Tyrer; T Barnes; C Bench; H Middleton; N Wright; S Paterson; W Shanahan; N Seivewright; C Ford
Journal:  Br J Psychiatry       Date:  2003-10       Impact factor: 9.319

6.  Psychopathology risk transmission in children of parents with substance use disorders.

Authors:  Duncan B Clark; Jack Cornelius; D Scott Wood; Michael Vanyukov
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

7.  Family functioning and parent support trajectories and substance use and misuse among minority urban adolescents: a latent class growth analysis.

Authors:  David Cordova; Justin Heinze; Ritesh Mistry; Hsing-Fang Hsieh; Sarah Stoddard; Christopher P Salas-Wright; Marc A Zimmerman
Journal:  Subst Use Misuse       Date:  2014-07-17       Impact factor: 2.164

8.  Familial transmission of substance use disorders.

Authors:  K R Merikangas; M Stolar; D E Stevens; J Goulet; M A Preisig; B Fenton; H Zhang; S S O'Malley; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1998-11

9.  Associations between substance use disorders and major depression in parents and late adolescent-emerging adult offspring: an adoption study.

Authors:  Naomi R Marmorstein; William G Iacono; Matt McGue
Journal:  Addiction       Date:  2012-07-12       Impact factor: 6.526

10.  Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Authors:  Rebecca Kuepper; Jenny Ceccarini; Johan Lataster; Jim van Os; Marinus van Kroonenburgh; Joop M A van Gerven; Machteld Marcelis; Koen Van Laere; Cécile Henquet
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.